Presentations and Posters
-
FOCUS article: UV1 vaccination in pembrolizumab-treated patients with recurrent or metastatic head and neck cancer (11.04.2025)
-
Prospectus: Business Combination Zelluna and Ultimovacs - incl. appendices (28.02.25)
-
Presentation og the Business combination of Zelluna and Ultimovacs
